Wildcat Capital Management, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 8Value: $187.4MLatest: 2025Q1

Wildcat Capital Management, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 8 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "CNTA",
  "ALLO",
  "ULCC",
  "RLX",
  null,
  "TIC",
  "KRON",
  "URGN"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-02
Total Holdings: 8
Total Value: 187387580
Accession Number: 0001999371-25-005352
Form Type: 13F-HR
CIK: wildcat-capital-management
Manager Name: Wildcat-Capital-Management

Data Enrichment

88% identified

7 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

8 positions • $187.4M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Frontier Group Holdings, Inc.

ULCC|35909R108

Shares:28.1M

Value:$121.8M

% of Portfolio:65.0% ($121.8M/$187.4M)

RLX Technology Inc.

RLX|74969N103

Shares:18.0M

Value:$33.9M

% of Portfolio:18.1% ($33.9M/$187.4M)

ACUREN CORP

TIC|00510N102

Shares:1.5M

Value:$16.7M

% of Portfolio:8.9% ($16.7M/$187.4M)

UroGen Pharma Ltd.

URGN|M96088105

Shares:495.6K

Value:$5.5M

% of Portfolio:2.9% ($5.5M/$187.4M)

Allogene Therapeutics, Inc.

ALLO|019770106

Shares:2.9M

Value:$4.3M

% of Portfolio:2.3% ($4.3M/$187.4M)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:281.9K

Value:$4.1M

% of Portfolio:2.2% ($4.1M/$187.4M)

Kronos Bio, Inc.

KRON|50107A104

Shares:1.3M

Value:$1.1M

% of Portfolio:0.6% ($1.1M/$187.4M)

G1281K122

Shares:113.4K

Value:$124.8K

% of Portfolio:0.1% ($124.8K/$187.4M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Frontier Group Holdings, Inc.(ULCCcusip35909R108)	28.1M	QoQ 0.00% (-0) YoY NEW(+28.1M)	All Managers (Combined)	$121.8M	65.0% ($121.8M/$187.4M)	QoQ -38.95% (-$77.7M) YoY NEW(+$121.8M)
RLX Technology Inc.(RLXcusip74969N103)	18.0M	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$33.9M	18.1% ($33.9M/$187.4M)	QoQ -12.96% (-$5.1M) YoY +10.47% (+$3.2M)
ACUREN CORP(TICcusip00510N102)	1.5M	QoQ NEW(+1.5M) YoY NEW(+1.5M)	All Managers (Combined)	$16.7M	8.9% ($16.7M/$187.4M)	QoQ NEW(+$16.7M) YoY NEW(+$16.7M)
UroGen Pharma Ltd.(URGNcusipM96088105)	495.6K	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$5.5M	2.9% ($5.5M/$187.4M)	QoQ +3.84% (+$203.2K) YoY -26.26% (-$2.0M)
Allogene Therapeutics, Inc.(ALLOcusip019770106)	2.9M	QoQ 0.00% (-0) YoY +52.06% (-1.0M)	All Managers (Combined)	$4.3M	2.3% ($4.3M/$187.4M)	QoQ -31.45% (-$2.0M) YoY -45.86% (-$3.6M)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	281.9K	QoQ NEW(+281.9K) YoY NEW(+281.9K)	All Managers (Combined)	$4.1M	2.2% ($4.1M/$187.4M)	QoQ NEW(+$4.1M) YoY NEW(+$4.1M)
Kronos Bio, Inc.(KRONcusip50107A104)	1.3M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.1M	0.6% ($1.1M/$187.4M)	QoQ -13.15% (-$162.2K) YoY -36.53% (-$616.5K)
(cusipG1281K122)✕	113.4K	QoQ 0.00% (-0) YoY NEW(+113.4K)	All Managers (Combined)	$124.8K	0.1% ($124.8K/$187.4M)	QoQ -45.27% (-$103.2K) YoY NEW(+$124.8K)